• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SURGIFLO HAEMOSTATIC MATRIX WITH THROMBIN; Agent, absorbable hemostatic, collagen based

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SURGIFLO HAEMOSTATIC MATRIX WITH THROMBIN; Agent, absorbable hemostatic, collagen based Back to Search Results
Model Number 2994
Medical Device Problem Code Device Handling Problem (3265)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No lot number is available.
 
Event or Problem Description
Event description: the sales representative reported that during an open reduction internal fixation (orif) procedure surgiflo was used, some of the patient's blood was salvaged and processed through a cell saver, and the processed blood was returned to the patient.The device is not available for return.Note in file: as per rep: "the surgical team was concerned that the blood may be contaminated with the particles of surgiflo cell saver.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGIFLO HAEMOSTATIC MATRIX WITH THROMBIN
Common Device Name
Agent, absorbable hemostatic, collagen based
Manufacturer Contact
sydmarken 5
soeborg, 2860
MDR Report Key23630787
Report Number3008478369-2025-00040
Device Sequence Number9317835
Product Code LMF
UDI-Device Identifier25712123000285
UDI-Public25712123000285
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
P990004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 11/21/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model Number2994
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/28/2025
Initial Report FDA Received Date11/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-